Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -200,124 | -123,161 | -58,218 | -143,805 | -115,845 |
| Depreciation Amortization | 480 | 980 | 533 | 1,569 | 1,005 |
| Accounts receivable | 1,669 | -3,000 | 1,750 | -1,750 | N/A |
| Accounts payable and accrued liabilities | 13,777 | 1,967 | -481 | 1,071 | 1,005 |
| Other Working Capital | 16,005 | 10,043 | -2,689 | 10,584 | -1,364 |
| Other Operating Activity | 18,944 | 23,868 | 9,302 | 31,453 | 21,319 |
| Operating Cash Flow | $-149,249 | $-89,303 | $-49,803 | $-100,878 | $-93,880 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -279,154 | 12,692 | 17,796 | -19,616 | 21,635 |
| PPE Investments | -625 | -451 | N/A | -3,072 | -2,303 |
| Investing Cash Flow | $-279,779 | $12,241 | $17,796 | $-22,688 | $19,332 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 850,793 | 6,274 | 1,282 | 277,858 | 274,058 |
| Other Financing Activity | -401 | -69 | -25 | -283 | -233 |
| Financing Cash Flow | $850,392 | $6,205 | $1,257 | $277,575 | $273,825 |
| Beginning Cash Position | 207,214 | 207,214 | 207,214 | 53,205 | 53,205 |
| End Cash Position | 628,578 | 136,357 | 176,464 | 207,214 | 252,482 |
| Net Cash Flow | $421,364 | $-70,857 | $-30,750 | $154,009 | $199,277 |
| Free Cash Flow | |||||
| Operating Cash Flow | -149,249 | -89,303 | -49,803 | -100,878 | -93,880 |
| Capital Expenditure | -625 | -451 | N/A | -3,072 | -2,303 |
| Free Cash Flow | -149,874 | -89,754 | -49,803 | -103,950 | -96,183 |